Table 4.
Tool | Target athletes | Aim | Number of parameters | Score (points) and criteria |
---|---|---|---|---|
EROS-CLINICAL | Suspected of OTS (possible signs of imminent or incipient OTS) | Diagnosis of OTS in suspected athletes, easy-to-perform and not time- or fund-consuming | 9 | 0–2 = excluded for OTS 3–5 = inconclusive 6–9 = diagnosis of OTS |
| ||||
EROS-SIMPLIFIED | Suspected of OTS when the diagnosis was not confirmed using the EROS-CLINICAL criteria | Diagnosis of OTS in suspected athletes when the diagnosis was not confirmed using the EROS-CLINICAL criteria | 13 | 0–3 = excluded for OTS 4–6 = inconclusive 7–8 = probable OTS 9–13 = diagnosis of OTS |
| ||||
EROS-COMPLETE | Population-based screenings; athletes participating in research Exception, suspected of OTS when the diagnosis was not confirmed using the EROS-SIMPLIFIED criteria |
Diagnosis of OTS in large populations of athletes, irrespective of the risk or probability of OTS Identification of risk factors, biomarkers, and tools for the prevention and diagnosis of OTS Exception, individual diagnosis of OTS when the diagnosis was not confirmed using the EROS-SIMPLIFIED criteria |
20 | 0–4 = excluded for OTS 5–10 = inconclusive 11–20 = diagnosis of OTS |
| ||||
EROS-RISK | At high risk for OTS (absence of clinical or biochemical signs) | Prevention of OTS in high-risk athletes | 11 | 0–1 = low risk of OTS 2–4 = moderate risk of OTS 5–6 = high risk of OTS 7–11 = imminent risk of OTS |
OTS = overtraining syndrome.